ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 425

Beyond Disease Activity: Patient Global Scores Also Reflect Treatment Expectations and Emotional Reactions to Living with Rheumatoid Arthritis

Susan J. Bartlett1, Maria Celia Bazan Bardales2 and Ines Colmegna3, 1Division of Rheumatology, Johns Hopkins University, Baltimore, MD, 2Rheumatology, McGill University, Montreal, QC, Canada, 3Rheumatology, McGill University - Royal Victoria Hospital, Montreal, QC, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: patient outcomes and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects: Novel Biomarkers and Other Measurements of Disease Activity

Session Type: Abstract Submissions (ACR)

Background/Purpose: Illness perceptions (IP) are the beliefs and expectations that an individual has about medical conditions. IP have been found to cluster around five coherent themes (identity; cause; time-line; consequences; and cure/control). Positive IPs have been associated with higher adherence, better disease outcomes and wellbeing in several chronic diseases. Relatively less is known about how illness perceptions impact patient perceptions of wellbeing and other disease outcomes in rheumatoid arthritis (RA).

Methods: Consecutive English speaking RA patients seen at an academic center between 2013- 2014 were asked to complete the Illness Perception Questionnaire – Revised (IPQ-R). Clinical RA indicators were obtained at each visit. Spearman correlations were calculated between IPQ-R scales and CDAI. Adjusted regression models evaluated the effect of IPQ-R on patient global scores.

Results: 50 RA patients completing the survey were mostly female (n=38;76%) with a mean (SD) education of 15 (4) yrs, and median (IQR) HAQ score of .25 (1.0). Eight (16%) had an RA duration ≤ 1 year and 20 (40%) of 1-5 years. Most were seropositive for RF (61%) and anti-CCP (66%); 15 (30%) were on biologics. CDAI scores classified 13 (26%) in remission and 18 (36%), 13 (26%) and 6 (12%) with low, moderate and high disease activity levels, respectively.

Timeline-Cyclic (rho = .32) and Personal Control (rho = .28) were significantly (p’s <.05) and directly associated with CDAI; Treatment Control (rho = -.40) was inversely related to CDAI in a dose response manner (mean difference 2.3 and 3.8 between remission, low, and mod-high levels). After controlling for disease activity, Treatment Control and Emotional Representations were independent additional predictors (p’s <.05) explaining 62% of the variance in patient global scores. Genetic risk factors (39%), altered immunity (26%) and psychological factors (24%) were viewed as the primary reason or an important contributing factor for developing RA. Patients who attributed their RA to psychological factors had significantly higher mean Cyclical Timeline scores (14.8 vs. 12.1; p=.004) reflecting attitudes of greater unpredictability and uncertainty around their disease.

Conclusion: Understanding patients’ beliefs about the cause of their RA, as well as expectations about controllability, may offer insight into patient behaviors (e.g., adherence to treatment) that impact long-term outcomes. Beliefs about causes of RA may also affect expectations of whether and how the disease can be controlled. Clinicians may find useful to directly explore patients’ expectancies around treatment, and to provide hope, encouragement and ongoing support when expectations are low.


Disclosure:

S. J. Bartlett,
None;

M. C. Bazan Bardales,
None;

I. Colmegna,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/beyond-disease-activity-patient-global-scores-also-reflect-treatment-expectations-and-emotional-reactions-to-living-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology